SCHEMBL7942707

SCHEMBL7942707

O=C1N=c2ccc3ccccc3c2=NC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
CYP2A6 P11509 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PAX8 Q06710 1/20 0.42
DNMT1 P26358 1/20 0.40
HPRT1 P00492 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
HIF1A Q16665 1/20 0.37
CYP1B1 Q16678 1/20 0.37
PARP1 P09874 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP3A4 P08684 1/20 0.34
CES1 P23141 1/20 0.34
TYMS P04818 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9795832 0.84 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL17743678 0.79 CA1 (0.39) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL17503355 0.71 PAX8 (0.37) ALDH1A1HSD17B10TDP1PAX8HPRT1
SCHEMBL10262240 0.67 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL6881238 0.67 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL7691627 0.67 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL268735 0.65 ALDH1A1 (0.65) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL29391827 0.65 ALDH1A1 (0.65) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL30186719 0.65 ALDH1A1 (0.65) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL21359837 0.65 MAPT (0.38) ALDH1A1TDP1KDM4EHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0696289-B1 BENZO[F]QUINOXALINDIONE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS SCHERING AG (DE) 1997-03-12 EP claimed
JP-10130247-A None JP disclosed
CN-119285640-A Naphthalene dione pyrazine fused ring compound and preparation method and application thereof 西京学院 2025-01-10 CN disclosed
US-6191132-B1 THERAPY FOR PARKINSON'S DISEASE; SYNERGISTIC MIXTURE WITH ANTIDOPAMINE AGENT SCHERING AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
US-6057120-A Redox-active compounds and their use ROCHE DIAGNOSTICS GMBH (DE) 2000-05-02 US disclosed
CN-1041935-C Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs SCHERING AG (DE) 1999-02-03 CN disclosed
JP-H10130247-A REDOX ACTIVE COMPOUND AND USE THEREOF BOEHRINGER MANNHEIM GMBH 1998-05-19 JP disclosed
US-5721234-A TREATING CONVULSIONS, ANXIETY, CEREBRAL HYPOXIA/ISCHEMIA, PARKINSON*S DISEASE WARNER-LAMBERT COMPANY (US) 1998-02-24 US disclosed
US-5616586-A Tricyclic quinoxalinediones SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-04-01 US disclosed
WO-1996017832-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-06-13 WO disclosed
CN-1122136-A Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs SCHERING AG (DE) 1996-05-08 CN disclosed
WO-1993008188-A1 TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1993-04-29 WO disclosed